DE69305642D1 - Injizierbares Arzneimittel und Satz, die Omoprazol oder verwandte Verbindungenenthalten - Google Patents

Injizierbares Arzneimittel und Satz, die Omoprazol oder verwandte Verbindungenenthalten

Info

Publication number
DE69305642D1
DE69305642D1 DE69305642T DE69305642T DE69305642D1 DE 69305642 D1 DE69305642 D1 DE 69305642D1 DE 69305642 T DE69305642 T DE 69305642T DE 69305642 T DE69305642 T DE 69305642T DE 69305642 D1 DE69305642 D1 DE 69305642D1
Authority
DE
Germany
Prior art keywords
pct
omoprazole
related compounds
kit containing
injectable drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69305642T
Other languages
English (en)
Other versions
DE69305642T2 (de
Inventor
Shigeo Nakanishi
Tetsuo Tominaga
Iwao Yamanaka
Takashi Higo
Toshiyuki Shibata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astra AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=16437061&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69305642(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra AB filed Critical Astra AB
Publication of DE69305642D1 publication Critical patent/DE69305642D1/de
Application granted granted Critical
Publication of DE69305642T2 publication Critical patent/DE69305642T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Dental Preparations (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69305642T 1992-07-28 1993-07-15 Injizierbares Arzneimittel und Satz, die Omoprazol oder verwandte Verbindungenenthalten Expired - Fee Related DE69305642T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20120392 1992-07-28
PCT/JP1993/000998 WO1994002141A1 (en) 1992-07-28 1993-07-15 Injection and injection kit containing omeprazole and its analogs

Publications (2)

Publication Number Publication Date
DE69305642D1 true DE69305642D1 (de) 1996-11-28
DE69305642T2 DE69305642T2 (de) 1997-02-27

Family

ID=16437061

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69305642T Expired - Fee Related DE69305642T2 (de) 1992-07-28 1993-07-15 Injizierbares Arzneimittel und Satz, die Omoprazol oder verwandte Verbindungenenthalten

Country Status (20)

Country Link
US (1) US5589491A (de)
EP (1) EP0652751B1 (de)
KR (1) KR100258423B1 (de)
AT (1) ATE144421T1 (de)
AU (1) AU674015B2 (de)
CA (1) CA2140347C (de)
CZ (1) CZ284249B6 (de)
DE (1) DE69305642T2 (de)
DK (1) DK0652751T3 (de)
ES (1) ES2093445T3 (de)
FI (1) FI113338B (de)
GR (1) GR3021937T3 (de)
HK (1) HK52397A (de)
HU (1) HU226778B1 (de)
NO (1) NO304098B1 (de)
NZ (1) NZ254237A (de)
RU (1) RU2126252C1 (de)
SG (1) SG52479A1 (de)
SK (1) SK279554B6 (de)
WO (1) WO1994002141A1 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4324014C2 (de) * 1993-07-17 1995-06-08 Byk Gulden Lomberg Chem Fab Verfahren zur Herstellung einer in Wasser rekonstituierbaren Zubereitung
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6733778B1 (en) 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6316020B1 (en) * 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
SE9903831D0 (sv) * 1999-10-22 1999-10-22 Astra Ab Formulation of substituted benzimidazoles
WO2002015908A1 (fr) * 2000-08-18 2002-02-28 Takeda Chemical Industries, Ltd. Injections
WO2002026210A2 (en) * 2000-09-29 2002-04-04 Geneva Pharmaceuticals Inc. Proton pump inhibitor formulation
MY137726A (en) 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
US20020192299A1 (en) * 2000-12-28 2002-12-19 Rajneesh Taneja Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination
KR100467100B1 (ko) * 2002-03-20 2005-01-24 일양약품주식회사 2-[(4-메톡시-3-메틸)-2-피리디닐]메틸설피닐-5-(1Ｈ-피롤-1-릴)-1Ｈ-벤즈이미다졸 또는 이의 Ｎа염을 함유하는주사제의 제조방법
US20030228363A1 (en) * 2002-06-07 2003-12-11 Patel Mahendra R. Stabilized pharmaceutical compositons containing benzimidazole compounds
US20040081671A1 (en) * 2002-07-03 2004-04-29 Rajneesh Taneja Liquid dosage forms of non-enterically coated acid-labile drugs
US20040082618A1 (en) * 2002-07-03 2004-04-29 Rajneesh Taneja Liquid dosage forms of acid labile drugs
US20040006109A1 (en) * 2002-07-03 2004-01-08 Rajneesh Taneja Liquid dosage forms of non-enterically coated acid-labile drugs
US20070243251A1 (en) * 2002-12-20 2007-10-18 Rajneesh Taneja Dosage Forms Containing A PPI, NSAID, and Buffer
US20040121004A1 (en) * 2002-12-20 2004-06-24 Rajneesh Taneja Dosage forms containing a PPI, NSAID, and buffer
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
AR045258A1 (es) * 2003-08-21 2005-10-19 Altana Pharma Ag Un producto farmaceutico para inyeccion
BRPI0416027A (pt) 2003-11-05 2007-01-02 Lyka Labs Ltd sistema de entrega de drogas para inibidores de bomba de prótons e processo resultante
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20070026071A1 (en) * 2005-07-28 2007-02-01 Qpharma, Llc Magnesium salt proton pump inhibitor dosage forms
WO2007091276A2 (en) * 2006-02-10 2007-08-16 Rajasthan Antibiotic Limited Novel crystal form of omeprazol sodium
CN104288175A (zh) * 2014-09-17 2015-01-21 大生祥(武汉）中医投资管理有限公司 一种新的苯并咪唑类异构体制剂及其制备方法
CN105919953A (zh) * 2016-06-27 2016-09-07 峨眉山通惠制药有限公司 一种注射用奥美拉唑钠组合物及其制作工艺
GB2585628A (en) * 2019-05-08 2021-01-20 Alkaloid Ad Pharmaceutical formulation
CN112807282A (zh) * 2021-01-13 2021-05-18 海南葫芦娃药业集团股份有限公司 一种奥美拉唑钠冻干粉针剂及其制备方法
WO2024075017A1 (en) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition of aortic valve calcification

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
US4472409A (en) * 1981-11-05 1984-09-18 Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
DK399389A (da) * 1988-08-18 1990-02-19 Takeda Chemical Industries Ltd Injicerbare oploesninger
DK0382489T3 (da) * 1989-02-10 1995-01-16 Takeda Chemical Industries Ltd Monoklonalt anti-humant papillomvirusantistof, hybridomcelle, der producerer dette, samt fremgangsmåde til fremstilling deraf
US5049674A (en) * 1989-12-20 1991-09-17 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles

Also Published As

Publication number Publication date
GR3021937T3 (en) 1997-03-31
CA2140347A1 (en) 1994-02-03
RU2126252C1 (ru) 1999-02-20
SG52479A1 (en) 1998-09-28
KR950702419A (ko) 1995-07-29
SK279554B6 (sk) 1998-12-02
DK0652751T3 (da) 1996-11-18
FI950379A0 (fi) 1995-01-27
AU674015B2 (en) 1996-12-05
EP0652751B1 (de) 1996-10-23
FI950379A (fi) 1995-01-27
ES2093445T3 (es) 1996-12-16
ATE144421T1 (de) 1996-11-15
CA2140347C (en) 2001-03-27
US5589491A (en) 1996-12-31
WO1994002141A1 (en) 1994-02-03
NZ254237A (en) 1995-12-21
AU4583893A (en) 1994-02-14
HUT71900A (en) 1996-02-28
DE69305642T2 (de) 1997-02-27
CZ284249B6 (cs) 1998-10-14
NO950178D0 (no) 1995-01-17
HK52397A (en) 1997-05-02
KR100258423B1 (ko) 2000-07-01
EP0652751A1 (de) 1995-05-17
NO950178L (no) 1995-01-17
HU9500245D0 (en) 1995-03-28
SK10095A3 (en) 1995-07-11
NO304098B1 (no) 1998-10-26
FI113338B (fi) 2004-04-15
CZ21795A3 (en) 1995-10-18
HU226778B1 (en) 2009-10-28

Similar Documents

Publication Publication Date Title
DE69305642D1 (de) Injizierbares Arzneimittel und Satz, die Omoprazol oder verwandte Verbindungenenthalten
DK0697019T3 (da) Risperidon pamoater
ATE167476T1 (de) Substituierte 2-phenyl-3-methocypropensäurenester als fungizide mittel.
GEP20022627B (en) N-Hydroxy-2-(Alkyl, Aryl, or Heteroaryl Sulfanyl, Sulfinil or Sulfonyl)-3-Substituted Alkyl, Aryl or Heteroarylamides as Matrix Metalloproteinase Inhibitors
ATE248824T1 (de) Substituierte phenylderivate, ihre herstellung und verwendung
NO308794B1 (no) Farmakologisk aktive pyridin-derivater, preparater inneholdende forbindelsene samt forbindelsenes anvendelse
ATE211466T1 (de) Depsipeptide, herstellung und anwendung
PT790824E (pt) Acidos carboxilicos 2,2-dicloroalcanos medicamentos contendo os mesmos e o seu uso para o tratamento da resistencia a insulina
YU46998B (sh) Postupak za dobijanje derivata cefema i medjuproizvoda za iste
MX9203125A (es) Compuestos con actividad similar a la insulina, antidiabeticos.
NO980531L (no) Medikament for å hemme avhengighet og toleranse utviklet ved narkotisk smertestillende middel
KR900701262A (ko) 췌장염 등에 대한 치료제
DK0617035T3 (da) Hetero-tricyclisk-substituerede phenyl-cyclohexan-carboxylsyrederivater.
ES2096099T3 (es) Perhidro-1h-pirido(1,2,a)pirazinas 2-sustituidas neurolepticas.
ATE75399T1 (de) Therapeutikum zur behandlung von magengeschwueren.
ATE88634T1 (de) Arzneimittel zur behandlung von herzinsuffizienz.
DE69619088D1 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
EP0372582A3 (de) 6-Aminoalkyl-carbapeneme
TH2754A (th) กรรมวิธีเตรียม 4-((ไบไซคลิดเฮเทอโรไซคลิล)-เมธิลและ-เฮเทอโร)-พิเพอริดิน
SU1829367A1 (ru) 5-(1-гидрокси-1-метоксикарбонил-2,2,2-трифторэтил)-8-трибутилоловооксихинолин, проявляющий антистафилококковую активность
SU1531433A1 (ru) 4-(n-Фторфенил)-5-фенил-2-(α-гидрокси-α -карбометокситрифторэтил)-тиофен, проявляющий антимикробную и противовоспалительную активность

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee